BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Anticancer properties of distinct antimalaria drug classes

Dataset: Anticancer properties of distinct antimalaria drug classes

Background: Antimalarials have anticancer potential. Results: We have systematically tested five distinct antimalaria drugs in a panel...

Registered by ArrayExpress Uploader
View Dataset

Background: Antimalarials have anticancer potential. Results: We have systematically tested five distinct antimalaria drugs in a panel of cancer cell lines. Conclusion: Three antimalarial classes display potent antiproliferative activity, and their potency is correlated with cancer cell gene expression patterns. Significance: We confirm and extend anticancer potential of these antimalarials and we discuss their therapeutic potential based on clinical data. Key words: Malaria, Anticancer drug, Drug Discovery, Genomics, Gene Expression, Bioinformatics, Cancer Affymetrix® HG-U133 Plus 2.0 mRNA expression arrays were used to determine the expression. CEL result files were pre-processed using the RMA (Irizarry et al, 2003) algorithm. This microarray analysis was performed for 91 cell lines.

Species:
human

Samples:
91

Source:
E-GEOD-51739

Updated:
Dec.12, 2014

Registered:
Jul.11, 2014


Factors: (via ArrayExpress)
Sample DIFFERENTIATION ORIGIN AGE CELL LINE SEX
GSM1251860 not known primary 72 1752 male
GSM1251859 poor primary 56 269 male
GSM1251858 not known not known 32 KCL-22 female
GSM1251857 poor not known Not available PC-3M male
GSM1251856 poor not known 11 Raji male
GSM1251855 not known not known 62 NCI-H929 female
GSM1251854 not known primary 51 486 female
GSM1251853 not known metastasis 22 276 male
GSM1251852 not known primary 55 698 male
GSM125185 not known not known 59 KG-1 male
GSM1251850 poor primary 60 251 male
GSM1251849 moderate primary 70 94 male
GSM1251848 not known not known 73 JURL-MK1 male
GSM1251847 good metastasis 70 546 male
GSM1251846 poor metastasis 63 289 male
GSM1251845 poor metastasis 58 526 male
GSM1251844 poor not known Not available NCI-H460 male
GSM1251843 poor primary 19 MOLT-4 male
GSM1251842 not known not known 11 Saos-2 female
GSM125184 poor primary 56 1121 female
GSM1251840 poor recurrent 43 1781 male
GSM1251839 not known metastasis 41 520 male
GSM1251838 not known metastasis 35 1341 female
GSM1251837 not known not known 60 NIH:OVCAR-3 female
GSM1251836 not known primary 74 1183 male
GSM1251835 poor not known 53 K-562 female
GSM1251834 poor not known 69 MCF-7 female
GSM1251833 not known not known 81 T-24 female
GSM1251832 poor not known Not available IM-9 female
GSM125183 not known metastasis 63 462 male
GSM1251830 not known not known 24 PL-21 male
GSM1251829 poor not known Not available RKO Not available
GSM1251828 good metastasis 51 401 female
GSM1251827 poor not known Not available HCT-116 male
GSM1251826 poor not known 51 MDA-MB-231 female
GSM1251825 poor not known 14 Jurkat male
GSM1251824 good primary 76 899 female
GSM1251823 not known not known 56 lp-1 female
GSM1251822 poor not known 36 HL-60 female
GSM125182 poor not known 44 HT-29 female
GSM1251820 moderate metastasis 60 1657 female
GSM1251819 good primary 66 575 male
GSM1251818 not known primary 55 MEG-01 male
GSM1251817 poor not known Not available 22Rv1 male
GSM1251816 poor not known 69 DU-145 male
GSM1251815 not known not known 56 CAL-27 male
GSM1251814 poor not known 37 U-937 male
GSM1251813 not known not known 7 TE671 female
GSM1251812 not known primary 5 EM-2 female
GSM12518 poor metastasis 66 1138 female
GSM1251810 poor metastasis 52 1352 male
GSM1251809 poor recurrent 73 1118 female
GSM1251808 poor metastasis Not available 1218 female
GSM1251807 not known not known 31 NOMO-1 female
GSM1251806 good not known 53 HUT-78 male
GSM1251805 not known not known 56 PANC-1 male
GSM1251804 not known not known 10 MV4-11 male
GSM1251803 poor metastasis 55 1103 male
GSM1251802 not known metastasis 60 1792 male
GSM125180 poor not known 61 RPMI8226 male
GSM1251800 not known not known 65 OCI-AML2 male
GSM1251799 poor not known 50 LNCAP male
GSM1251798 poor primary 59 629 male
GSM1251797 poor not known 36 L-363 female
GSM1251796 poor primary 54 393 male
GSM1251795 poor primary 63 3011 male
GSM1251794 good metastasis 46 DiFi female
GSM1251793 poor primary 34 529 female
GSM1251792 poor metastasis 59 983 male
GSM125179 undifferentiated not known 57 JHH-6 female
GSM1251790 not known not known 51 JHH-4 male
GSM1251789 not known not known 57 JHH-2 male
GSM1251788 poor not known 38 OCUM-1 female
GSM1251787 poor metastasis 35 NUGC-4 female
GSM1251786 poor not known 62 MKN45 female
GSM1251785 moderate not known 63 IM95 male
GSM1251784 poor not known 66 Fu97 female
GSM1251783 not known not known 54 SNU-878 female
GSM1251782 not known not known 49 SNU-761 male
GSM125178 not known not known 52 SNU-739 male
GSM1251780 not known not known 43 SNU-475 male
GSM1251779 not known not known 52 SNU-449 male
GSM1251778 not known not known 40 SNU-423 male
GSM1251777 undifferentiated not known 68 HLE male
GSM1251776 not known not known 4 CCRF-CEM-VCR female
GSM1251775 not known not known Not available SNU-899 Not available
GSM1251774 not known not known Not available SNU-1076 Not available
GSM1251773 poor not known 62 498 male
GSM1251772 poor not known 4 CCRF-CEM female
GSM125177 not known not known 72 MKN1 male
GSM1251770 good not known 39 MKN7 male

Tags

  • cancer
  • cell
  • malaria

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2025 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use